跳至主要内容
临床试验/NCT04720040
NCT04720040已完成不适用

Using YMS-201B in Patients With Mild to Moderate Major Depressive Disorder To Evaluate Efficacy and Safety for the Effect of Improving Depressive Symptoms Open, Single-group, Multicenter Confirmatory Clinical Trial

Ybrain Inc.2 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2019年12月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Ybrain Inc.
入组人数
65
试验地点
2
主要终点
Korean-Beck Depression Inventory-II

研究概览

简要总结

This study evaluated the effectiveness and safety of improving depressive symptoms by applying tDCS for 6 weeks to patients with mild to moderate depression.

详细描述

Patients received tDCS for 30 minutes with an intensity of 1.5 to 2 mA. tDCS was applied over the left (anode) and right (cathode) dorsolateral prefrontal cortex (DLPFC) 5~7 times a week and they were evaluated every 2weeks through questionnaires.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Has a diagnosis of a major depressive disorder as confirmed by the DSM-V and MINI (without psychotic features)
  • Patients with a K-BDI-II score of 14 or more and 28 or less
  • In the case of patients who have previously administered antidepressants, antipsychotics, and anticonvulsants for at least 1 week, Patients with sufficient drug treatment periods of at least 5 times the drug half-life.

排除标准

  • Patients diagnosed with Axis I disorders other than major depressive disorder
  • Patients diagnosed with other depressive disorders besides major depressive disorder
  • Patients who have attempted suicide within 6 months of screening
  • Patients who are considered to have problems with EEG and DC stimulation electrode attachment due to scalp deformity, inflammatory reaction, or other dermatological problems
  • Patients judged to have other reasons for prohibition of use of tDCS medical devices
  • Patients currently taking antidepressants

结局指标

主要结局

Korean-Beck Depression Inventory-II

时间窗: At 6 weeks after treatment.

Average change of K-BDI-II at 6 weeks after treatment compare to the base respectively. This scale contains 21 questions, each answer being scored on a scale value of 0 to 3. Higher total scores indicate more severe depressive symptoms.The lower the total score, the better the symptoms.

次要结局

  • Korean-Beck Anxiety Depression Inventory(Weeks 0, 2, 4, and 6)
  • Hamilton Rating Scale for Depression(Weeks 0, 2, 4, and 6)

研究者

发起方
Ybrain Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验